Keywords: fda, approves, elan, zanaflex, spasticity, subsidiary, athena

FDA Approves Elan's Zanaflex For Spasticity

Article | 09 December 1996

Print This

Elan subsidiary Athena Neurosciences has been granted approval by the US Food and Drug Administration for its alpha-2 adrenoreceptor agonist ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in